FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

DAC-CEL T3 UPTAKE

K Number: K810212 · Decision Feb 10, 1981
Classifications
1
FEI Numbers
33
Registration Numbers
33
Same Product Code
92
Applicant Total
17
Review Days
14

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
DAC-CEL T3 UPTAKE
K Number
K810212
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
862.1715
Medical Specialty
Clinical Chemistry
Decision
Substantially Equivalent
Applicant
Burroughs Wellcome Co.
Date Received
January 27, 1981
Decision Date
February 10, 1981
Product Code
KHQ
Advisory Committee
Clinical Chemistry
Review Advisory Committee
CH
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
KHQ Radioassay, Triiodothyronine Uptake

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (KHQ), ordered by most recent decision date.

View all

Other Clearances by Burroughs Wellcome Co.

K Number Device Name
K820069 WELLCOGEN GROUP B
K813508 SAC-CEL
K810215 DAC-CEL HCG
K810214 DAC-CEL DIAGNATAL
K810213 DAC-CEL TSH
K791231 DAC-CEL T4
K791232 DAC-CEL T3
K781607 STREP-TEX
K780873 THYMUNE-M
K780874 THYMUNE-T
Search all 17 clearances from Burroughs Wellcome Co. →